TriNetX数据库中梅毒性葡萄膜炎及相关眼部并发症的发病率和患病率
基于美国TriNetX数据库2013至2024年的趋势研究,共识别237例梅毒性葡萄膜炎患者,最常见合并性传播感染为HIV(32.49%),最常见眼部并发症为低视力和盲(27.85%),累积发病率和患病率分别为每10万人0.36例和0.27例。
要点
- 梅毒性葡萄膜炎患者中男性占75.10%,白种人占53.58%,平均年龄52岁。
- 合并HIV感染最常见(32.49%),低视力和盲是最常见眼部并发症(27.85%)。
- 全葡萄膜炎或后葡萄膜炎患者中低视力和盲的比例最高(78.79%)。
核心结论
- 2013至2024年梅毒性葡萄膜炎的发病率和患病率上升,与美国总体梅毒流行趋势一致。
- 作者认为应对葡萄膜炎患者进行梅毒螺旋体和非螺旋体血清学检测,并及时干预以预防不可逆的视力并发症。
研究设计与样本
- 趋势研究,使用美国TriNetX数据库。
- 研究对象为2013至2024年根据国际疾病分类(ICD)葡萄膜炎编码识别,且葡萄膜炎诊断后1个月内梅毒螺旋体和非螺旋体检测均阳性的梅毒性葡萄膜炎患者。
- 从2013至2024年计算发病率和患病率数据,并收集人口学、合并其他性传播感染(HIV、淋病、衣原体)及眼部并发症(黄斑水肿和低视力)数据。
主要发现
- TriNetX总人群81 759 791人中,识别出161 317例梅毒和237例梅毒性葡萄膜炎。
- 237例梅毒性葡萄膜炎患者中,白种人占53.58%(N=127,95%CI 47.2%-59.9%),男性占75.10%(N=178,95%CI 69.6%-80.6%),平均年龄52岁(范围20-90,标准差15)。
- 最常见合并性传播感染为HIV,占32.49%(95%CI 26.53%-38.45%,N=77)。
- 最常见眼部并发症为低视力和盲,占27.85%(95%CI 22.16%-33.54%,N=66);其中全葡萄膜炎或后葡萄膜炎队列的低视力和盲比例最高,为78.79%(N=52)。
- 2013至2024年期间梅毒性葡萄膜炎的累积发病率和患病率分别为每10万人0.36例和0.27例。
临床怎么用
- 作者认为应对葡萄膜炎患者进行梅毒螺旋体和非螺旋体血清学检测。
- 作者认为应及时干预以预防不可逆的视力并发症。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To determine the yearly and cumulative incidences and prevalences of syphilitic uveitis, concurrent sexually transmitted infections, and ocular complications using the United States TriNetX database. DESIGN: Trend study. PARTICIPANTS: Subjects with syphilitic uveitis in the TriNetX database. METHODS: Subjects with syphilitic uveitis from 2013 to 2024 were identified with International Classification for Disease (ICD) codes for uveitis with the constraint of a positive treponemal and nontreponemal test for syphilis within 1 month after the diagnosis of uveitis. Incidence and prevalence data were calculated from 2013 to 2024. Additional data collected included demographics, concurrent infection with other sexually transmitted infections (STI- HIV, gonorrhea, chlamydia), and ocular complications (macular edema and low vision). MAIN OUTCOME MEASURES: The primary outcomes were the incidence and prevalence of syphilitic uveitis (annual and cumulative). Secondary outcomes were the incidence and prevalence of concurrent sexually transmitted infections and ocular complications (annual and cumulative). RESULTS: From the 81 759 791 total population in TriNetx, 161 317 cases of syphilis and 237 cases of syphilitic uveitis were identified. Of the 237 patients with syphilitic uveitis, 53.58% (N = 127, 95% CI 47.2%-59.9%) were White and 75.10% (N = 178, 95% CI 69.6%-80.6%) were male, with a mean age of 52 years (Range: 20-90, SD = 15). The most common STI co-infection was HIV (32.49%, 95% CI 26.53%-38.45%, N = 77). The most prevalent ocular complication was low vision and blindness (27.85%, 95% CI 22.16%-33.54%, N = 66); of which, the highest rates of low vision and blindness were in the cohorts with pan or posterior uveitis (78.79%, N = 52). The cumulative incidence and prevalence rates of syphilitic uveitis over the 2013 to 2024 period were 0.36 and 0.27 cases per 100 000, respectively. CONCLUSIONS: The rising incidence and prevalence of syphilitic uveitis from 2013 to 2024 mirrors the overall syphilis epidemic in the United States. This study highlights the need for serologic testing with treponemal and nontreponemal tests for syphilis in patients with uveitis and timely intervention to prevent irreversible visual complications.
引用
- Zhou LR, Kirupaharan N, Berkenstock MK, et al. Incidence and Prevalence of Syphilitic Uveitis and Associated Ocular Complications in the TriNetX Database. Am J Ophthalmol. 2025. PMID: 40480345. doi:10.1016/j.ajo.2025.05.048
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。